The Clinical Research Services Group of Reliance Life Sciences is building a global business that provides world-class product development services to pharmaceutical, biotechnology and medical device companies. Headquartered in India, the Clinical Research Services Group also has offices in Europe. The Phase I and Bioavailability - Bioequivalence clinics are located in Navi Mumbai and Bangalore, India.

Reliance Life Sciences offers a comprehensive range of services covering:

  • Regulatory Toxicity Studies
  • Bioavailability - Bioequivalence (BA / BE) Studies
  • Pharmacokinetics
  • Cardiac Safety
  • Mass Balance Studies
  • Phase I to IV Clinical Trial Management and Monitoring
  • Data management and Biostatistics
  • Medical Writing
Reliance Life Sciences has extensive experience across various therapeutic domains. Key among these are:
  • Infectious diseases
  • Oncology
  • Vaccines
  • Cardiovascular diseases
  • Immunology
  • Dermatology
  • Psychiatry
  • Gynaecology
  • Endocrinology
  • Haemotology
  • Gastroentology
  • Orthopaedics
  • Virology
  • Neurology
  • Nephrology
  • Cardiovascular
  • Ophthalmology
All the clinical research studies are conducted in strict compliance with ICH-GCP guidelines and applicable Indian laws governing clinical research.

The pathology laboratory is accredited by the College of American Pathologists (CAP) and the National Accreditation Board for Laboratories (NABL), India. The Bioavailability/Bioequivalence centre has successfully done studies meeting the requirements of Indian Regulatory Authorities, US FDA, MHRA (UK), ANVISA Brazil, MPA (Sweden) and MOH (Turkey).

Animal House

Reliance Life Sciences has established a state-of-the-art, barrier-maintained animal facility for breeding and experimentation on small animals to meet internal, as well as client needs.

The facility breeds and maintains animals in individual ventilated cages (IVC) and conforms to the guidelines outlined by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA).

It is the only facility in India designed to carry out experiments on immuno-compromised animals in a class 10,000 facility.

Clinical Pharmacology

Reliance Life Sciences operates a three-clinic, 100-bed state-of-the-art clinical facility in Navi Mumbai, India and in Bangalore, India with 4 clinics for BA / BE studies, including facilities for studies on female volunteers. Additionally, Reliance Life Sciences also operates an 11-bed ICU facility for Phase I studies, with a complete cardiac monitoring and recording facility in Navi Mumbai. These facilities are supported by in-house pathology and bioanalytical facilities.

For more information please visit : www.relclin.com

To know more about Clinical Research Services, click here